Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-05 Sale | 2023-01-09 6:18 pm | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 212,500 | $108.74 | $23,106,230 | 13,622 (Direct) | View |
| 2021-11-26 Purchase | 2021-11-29 4:48 pm | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 4,974 | $102.44 | $509,539 | 13,276 (Direct) | View |
| 2021-04-13 Sale | 2021-04-15 6:01 pm | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 97,973 | $196.34 | $19,236,323 | 8,184 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-31 Ownership | 2026-01-08 4:21 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Director | 1 | $10.99 | 416,474 (Direct) | View |
| 2025-06-30 Option Award | 2025-07-01 4:19 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Director | 833 | $15.13 | 416,473 (Direct) | View |
| 2024-12-31 Option Award | 2025-01-03 4:04 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Director | 412 | $14.75 | 415,640 (Direct) | View |
| 2025-01-01 Option Award | 2025-01-03 4:04 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Director | 400,000 | $0 | 415,640 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-06 4:19 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 1,239 | $12.24 | 15,228 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-06 4:12 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 367 | $35.28 | 13,989 (Direct) | View |
| 2023-01-05 Exercise | 2023-01-09 6:18 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 187,500 | $7.15 | 13,622 (Direct) | View |
| 2023-01-05 Exercise | 2023-01-09 6:18 pm | N/A 2026-02-24 | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 212,500 | $0 | 13,622 (Direct) | View |
| 2023-01-05 Exercise | 2023-01-09 6:18 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 25,000 | $11.46 | 13,622 (Direct) | View |
| 2023-01-06 Option Award | 2023-01-09 6:18 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 39 | $62.3 | 13,622 (Direct) | View |
| 2022-07-05 Option Award | 2022-07-07 5:48 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 276 | $59.08 | 13,583 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 6:22 pm | 2023-03-01 2032-02-29 | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 13,470 | $80.59 | 13,470 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-12 5:31 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 31 | $63.82 | 13,307 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 5:31 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 118 | $137.12 | 8,302 (Direct) | View |
| 2021-02-27 Exercise | 2021-03-02 4:17 pm | N/A N/A | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 9,259 | $149.1 | 206,944 (Direct) | View |
| 2021-02-27 Exercise | 2021-03-02 4:17 pm | 2021-02-27 N/A | NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer | 9,259 | $0 | 206,944 (Direct) | View |